Recent Posts
- Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
 - Inalve raises 2m€ to accelerate the aquaculture transition toward a more sustainable industry
 - Amolyt Pharma Named ‘Biotech Company of the Year” at the LSX European Lifestars Awards
 - Greentech: MECAWARE secures €40m to become the leader in battery recycling and the production of strategic metals in France and Europe
 - Amolyt Pharma to Present Data on the Renal Effects of Eneboparatide, a PTHR1 Agonist in Phase 3 for the Treatment of Hypoparathyroidism, at the 39th Congress of the French Society of Endocrinology
 
Archives
- March 2024
 - December 2023
 - November 2023
 - October 2023
 - September 2023
 - June 2023
 - April 2023
 - March 2023
 - February 2023
 - January 2023
 - December 2022
 - October 2022
 - September 2022
 - August 2022
 - June 2022
 - May 2022
 - April 2022
 - March 2022
 - February 2022
 - October 2021
 - September 2021
 - August 2021
 - July 2021
 - May 2021
 - April 2021
 - March 2021
 - January 2021
 - December 2020
 - November 2020
 - October 2020
 - September 2020
 - July 2020
 - April 2020
 - January 2020
 - December 2019
 - November 2019
 - October 2019
 - September 2019
 - July 2019
 - March 2019
 - February 2019
 - December 2018
 - November 2018
 - December 2017
 - September 2017
 - April 2017